Anlon HealthcareNSE:AHCL 17 Market Cap is ₹8,451 Mil as of Jul. 03, 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Anlon Healthcare ranks worse than 61.72% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Anlon Healthcare's share price for the quarter that ended in Mar. 2026 was ₹11.138. Anlon Healthcare's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 532 Mil. Therefore, Anlon Healthcare's market cap for the quarter that ended in Mar. 2026 was ₹5,920 Mil.
Anlon Healthcare's quarterly market cap
increased
from Sep. 2025 (₹6,971 Mil) to Dec. 2025 (₹8,023 Mil) but then
declined
from Dec. 2025 (₹8,023 Mil) to Mar. 2026 (₹5,920 Mil).
Anlon Healthcare's annual market cap
stayed the same
from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then
increased
from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹5,920 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Anlon Healthcare's Enterprise Value for Today is ₹9,090 Mil.
Anlon Healthcare (NSE:AHCL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Anlon Healthcare Market Cap Related Terms
Anlon Healthcare Market Cap Historical Data
* Premium members only.
The historical data trend for Anlon Healthcare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anlon Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anlon Healthcare Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anlon Healthcare's Market Cap distribution charts can be found below:
* The bar in red indicates where Anlon Healthcare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Anlon Healthcare's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anlon Healthcare (NSE:AHCL) has a Market Cap of ₹8,451 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Anlon Healthcare and its competitors. According to the industry distribution chart, Anlon Healthcare ranks #632 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 61.7%.
Is Anlon Healthcare's Market Cap too high?
Anlon Healthcare's current Market Cap is ₹8,451 Mil. Based on the distribution chart, Anlon Healthcare ranks #632 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Anlon Healthcare ranks #632 out of 1024 companies for Market Cap. This places Anlon Healthcare in the lower half of its industry. The industry median Market Cap is 212.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.74, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Anlon Healthcare and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anlon Healthcare's current Market Cap is ₹8,451 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Market Cap of ₹8,451 Mil. The current Market Cap is ₹8,451 Mil. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Market Cap is ₹8,451 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score
Get the complete analysis for NSE:AHCL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
